Caplight Directory>Companies>Neosoma, Inc.-preview>Neosomainc


Neosoma, Inc.

Neosoma, Inc.

Private
Groton, MassachusettsHealthcare & Life Scienceshttps://www.neosomainc.com/

Last Round

Seed Round

Mar 27, 2026

Total Funding Raised

$2.18M

Company Overview

Neosoma, Inc. is a medical technology company that provides an AI-based, cloud-native software platform for brain tumor analysis from MRI scans.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Clinical Trials, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

AI medical imagingradiology AIneuro-oncology softwarebrain MRI analysistumor segmentationFDA-cleared AIlongitudinal trackingvolumetric analysisglioma analysisbrain metastasesclinical trial softwarePACS integrationMedTechusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neosoma, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neosoma, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 27, 2026
VC RoundJul 26, 2024
Convertible DebtAug 24, 2023
AngelNov 20, 2020
View all Funding Rounds

Key People

Founding team and executive leadership

Ken Kolodziej

CEO, Neosoma, Inc.

Executive Team

Neosoma, Inc. Investors

Notable investors and investment history

InvestorRounds
Filter FundSeed Round, VC Round
Beacon AngelsConvertible Debt
Alliance of AngelsConvertible Debt, Seed Round
TCA Venture GroupConvertible Debt, Angel, Seed Round
View all Investors

Neosoma, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neosoma, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neosoma, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGroton, Massachusetts
Employee Range10
Year Founded2019
Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.